Assessing the Risk of Progression From Asymptomatic Left Ventricular Dysfunction to Overt Heart Failure

JACC: Heart Failure - Tập 4 Số 4 - Trang 237-248 - 2016
Justin B. Echouffo‐Tcheugui1,2, Sebhat Erqou3, Javed Butler4, Clyde W. Yancy5, Gregg C. Fonarow6
1Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
2Rollins School of Public Health, Emory University, Atlanta, Georgia
3Cardiology Division, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
4Cardiology Division, Department of Medicine, Stony Brook University, Stony Brook, New York
5Cardiology Division, Department of Medicine, Northwestern Feinberg School of Medicine, Chicago, Illinois
6Ahmanson-UCLA Cardiomyopathy Center, Division of Cardiology, Department of Medicine, Ronald Reagan-UCLA Medical Center, Los Angeles, California

Tóm tắt

Từ khóa


Tài liệu tham khảo

Mozaffarian, 2014, Heart disease and stroke statistics—2015 update: a report from the American Heart Association, Circulation, 131, e29, 10.1161/CIR.0000000000000152

Hunt, 2005, J Am Coll Cardiol, 46, e1, 10.1016/j.jacc.2005.08.022

Ammar, 2007, Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association heart failure staging criteria in the community, Circulation, 115, 1563, 10.1161/CIRCULATIONAHA.106.666818

Wang, 2003, The epidemiology of “asymptomatic” left ventricular systolic dysfunction: implications for screening, Ann Intern Med, 138, 907, 10.7326/0003-4819-138-11-200306030-00012

Lloyd-Jones, 2002, Lifetime risk for developing congestive heart failure: the Framingham Heart Study, Circulation, 3068, 10.1161/01.CIR.0000039105.49749.6F

Wang, 2003, Natural history of asymptomatic left ventricular systolic dysfunction in the community, Circulation, 108, 977, 10.1161/01.CIR.0000085166.44904.79

Lam, 2011, Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community, Circulation, 124, 24, 10.1161/CIRCULATIONAHA.110.979203

Aurigemma, 2001, Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study, J Am Coll Cardiol, 37, 1042, 10.1016/S0735-1097(01)01110-X

Pandhi, 2011, Comparison of characteristics and outcomes of asymptomatic versus symptomatic left ventricular dysfunction in subjects 65 years old or older (from the Cardiovascular Health Study), Am J Cardiol, 107, 1667, 10.1016/j.amjcard.2011.01.051

Harris, 2001, Current methods of the US Preventive Services Task Force: a review of the process, Am J Prev Med, 3, 21, 10.1016/S0749-3797(01)00261-6

Yeboah, 2012, Prognosis of individuals with asymptomatic left ventricular systolic dysfunction in the Multi-Ethnic Study of Atherosclerosis (MESA), Circulation, 126, 2713, 10.1161/CIRCULATIONAHA.112.112201

The Cochrane Collaboration. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. Available from www.cochrane-handbook.org. Accessed November 23, 2015.

1992, Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions, N Engl J Med, 327, 685, 10.1056/NEJM199209033271003

Correa de Sa, 2010, Progression of preclinical diastolic dysfunction to the development of symptoms, Heart, 96, 528, 10.1136/hrt.2009.177980

From, 2010, The development of heart failure in patients with diabetes mellitus and pre-clinical diastolic dysfunction: a population-based study, J Am Coll Cardiol, 55, 300, 10.1016/j.jacc.2009.12.003

Verdecchia, 2005, Asymptomatic left ventricular systolic dysfunction in essential hypertension: prevalence, determinants, and prognostic value, Hypertension, 45, 412, 10.1161/01.HYP.0000154822.37141.f6

Bibbins-Domingo, 2009, Racial differences in incident heart failure among young adults, N Engl J Med, 360, 1179, 10.1056/NEJMoa0807265

Ren, 2007, Prevalence and prognosis of asymptomatic left ventricular diastolic dysfunction in ambulatory patients with coronary heart disease, Am J Cardiol, 99, 1643, 10.1016/j.amjcard.2007.01.041

Vogel, 2012, The natural history of preclinical diastolic dysfunction: a population-based study, Circ Heart Fail, 5144

Kane, 2011, Progression of left ventricular diastolic dysfunction and risk of heart failure, JAMA, 306, 856, 10.1001/jama.2011.1201

2006, Section 7: heart failure in patients with left ventricular systolic dysfunction, J Card Fail, 12, e38, 10.1016/j.cardfail.2005.11.012

Pfeffer, 1990, Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications, Circulation, 81, 1161, 10.1161/01.CIR.81.4.1161

Mann, 1999, Mechanisms and models in heart failure: a combinatorial approach, Circulation, 100, 999, 10.1161/01.CIR.100.9.999

Cohn, 2000, Cardiac remodeling—concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling, J Am Coll Cardiol, 35, 569, 10.1016/S0735-1097(99)00630-0

Moss, 2002, Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction, N Engl J Med, 346, 877, 10.1056/NEJMoa013474

Kuznetsova, 2015, Longitudinal changes in left ventricular diastolic function in a general population, Circ Cardiovasc Imaging, 8, e002882, 10.1161/CIRCIMAGING.114.002882

Wan, 2014, Pre-clinical diastolic dysfunction, J Am Coll Cardiol, 63, 407, 10.1016/j.jacc.2013.10.063

Zile, 2015, Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin, Circulation, 131, 1247, 10.1161/CIRCULATIONAHA.114.013215

Exner, 1999, Beta-adrenergic blocking agent use and mortality in patients with asymptomatic and symptomatic left ventricular systolic dysfunction: a post hoc analysis of the Studies of Left Ventricular Dysfunction, J Am Coll Cardiol, 33, 916, 10.1016/S0735-1097(98)00675-5

Colucci, 2007, Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trial, Circulation, 116, 49, 10.1161/CIRCULATIONAHA.106.666016

Ledwidge, 2013, Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial, JAMA, 310, 66, 10.1001/jama.2013.7588

Bursi, 2006, Systolic and diastolic heart failure in the community, JAMA, 296, 2209, 10.1001/jama.296.18.2209

Redfield, 2003, Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic, JAMA, 289, 194, 10.1001/jama.289.2.194

Coglianese, 2012, Clinical monitoring of stage B heart failure: echocardiography, Heart Fail Clin, 8, 169, 10.1016/j.hfc.2011.11.007

Kalogeropoulos, 2012, Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study, J Am Coll Cardiol Img, 5, 131, 10.1016/j.jcmg.2011.11.011

Gupta, 2014, Imaging in heart failure with preserved ejection fraction, Heart Fail Clin, 10, 419, 10.1016/j.hfc.2014.04.004

Partington, 2012, Cardiac magnetic resonance imaging for stage B heart failure, Heart Fail Clin, 8, 179, 10.1016/j.hfc.2011.11.009